Bioactive black tea phytochemicals partially influenced doxorubicin sensitivity by modulation of NRF2-regulatory pathways in lung cancer

IF 2.1 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Suchisnigdha Datta , Anupam Bishayee , Dona Sinha
{"title":"Bioactive black tea phytochemicals partially influenced doxorubicin sensitivity by modulation of NRF2-regulatory pathways in lung cancer","authors":"Suchisnigdha Datta ,&nbsp;Anupam Bishayee ,&nbsp;Dona Sinha","doi":"10.1016/j.jaim.2025.101297","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Lung cancer therapy resistance is often associated with the redox-regulatory nuclear factor erythroid 2-related factor-2 (NRF2)-Kelch-like ECH-associated protein1 (KEAP1) dysfunction.</div></div><div><h3>Objective</h3><div>This study investigated the impact of commercially available black tea (BT) phytochemicals (≥80 % theaflavins) from <em>Camellia sinensis</em> in sensitizing doxorubicin (Dox) against nonresponsive lung adenocarcinoma cells by modulation of non-canonical NRF2 regulators.</div></div><div><h3>Methods</h3><div>The methods included multidrug resistance (MDR) assay, comet assay, cell cycle analysis, zymography, semi-quantitative polymerase chain reaction, western blot and immunocytochemistry (ICC).</div></div><div><h3>Results</h3><div>BT pretreatment followed by Dox exposure was partially effective in Dox resistance-reversal in A549 cells by increasing drug uptake and downregulating MDR pumps. This combination induced DNA damage and cytotoxicity in A549 cells. It also reduced invasiveness and suppressed the expression of multidrug resistance protein-1, epidermal growth factor receptor, protein kinase B, and B cell lymphoma-2. In absence of wild-type KEAP1, non-KEAP1 regulators were thoroughly investigated by immunolocalization, and immunoblotting. BT restricted non-canonical NRF2 activators, such as p21 and apurinic/apyrimidinic endonuclease1 in A549 and acted oppositely in NCI–H23 cells. Additionally, NRF2-repressors, namely forkhead box O3, p53, glycogen synthase kinase-3β, and retinoid X receptor (RXR), were downregulated in NCI–H23 and upregulated in A549 cells. ICC exhibited that BT modulated the co-localization of NRF2 regulators, such as β-transducin repeat-containing protein and RXR, in A549 and NCI–H23 cells.</div></div><div><h3>Conclusion</h3><div>Therefore, it might be indicated that BT improved Dox retention and increased the Dox responsiveness in A549 cells. BT-mediated selective suppression of the NRF2, re-stabilized the KEAP-1-independent NRF2 regulators and made the non-responsive A549 cells partially sensitive to Dox.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 1","pages":"Article 101297"},"PeriodicalIF":2.1000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0975947625001731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Lung cancer therapy resistance is often associated with the redox-regulatory nuclear factor erythroid 2-related factor-2 (NRF2)-Kelch-like ECH-associated protein1 (KEAP1) dysfunction.

Objective

This study investigated the impact of commercially available black tea (BT) phytochemicals (≥80 % theaflavins) from Camellia sinensis in sensitizing doxorubicin (Dox) against nonresponsive lung adenocarcinoma cells by modulation of non-canonical NRF2 regulators.

Methods

The methods included multidrug resistance (MDR) assay, comet assay, cell cycle analysis, zymography, semi-quantitative polymerase chain reaction, western blot and immunocytochemistry (ICC).

Results

BT pretreatment followed by Dox exposure was partially effective in Dox resistance-reversal in A549 cells by increasing drug uptake and downregulating MDR pumps. This combination induced DNA damage and cytotoxicity in A549 cells. It also reduced invasiveness and suppressed the expression of multidrug resistance protein-1, epidermal growth factor receptor, protein kinase B, and B cell lymphoma-2. In absence of wild-type KEAP1, non-KEAP1 regulators were thoroughly investigated by immunolocalization, and immunoblotting. BT restricted non-canonical NRF2 activators, such as p21 and apurinic/apyrimidinic endonuclease1 in A549 and acted oppositely in NCI–H23 cells. Additionally, NRF2-repressors, namely forkhead box O3, p53, glycogen synthase kinase-3β, and retinoid X receptor (RXR), were downregulated in NCI–H23 and upregulated in A549 cells. ICC exhibited that BT modulated the co-localization of NRF2 regulators, such as β-transducin repeat-containing protein and RXR, in A549 and NCI–H23 cells.

Conclusion

Therefore, it might be indicated that BT improved Dox retention and increased the Dox responsiveness in A549 cells. BT-mediated selective suppression of the NRF2, re-stabilized the KEAP-1-independent NRF2 regulators and made the non-responsive A549 cells partially sensitive to Dox.

Abstract Image

生物活性红茶植物化学物质通过调节肺癌中nrf2调控通路部分影响阿霉素敏感性。
背景:肺癌治疗耐药常与氧化还原调节核因子红系2相关因子-2 (NRF2)- kelch样ECH-associated protein1 (KEAP1)功能障碍有关。目的:研究市售红茶(BT)植物化学物质(≥80%茶黄素)通过调节非规范NRF2调节因子使阿霉素(Dox)对无应答肺腺癌细胞增敏的影响。方法:采用多药耐药(MDR)试验、彗星试验、细胞周期分析、酶谱分析、半定量聚合酶链反应、western blot和免疫细胞化学(ICC)等方法。结果:BT预处理后的Dox暴露可通过增加药物摄取和下调MDR泵来部分逆转A549细胞的Dox耐药。该组合诱导了A549细胞的DNA损伤和细胞毒性。它还能降低侵袭性,抑制多药耐药蛋白-1、表皮生长因子受体、蛋白激酶B和B细胞淋巴瘤-2的表达。在缺乏野生型KEAP1的情况下,通过免疫定位和免疫印迹彻底研究了非KEAP1调节因子。BT在A549中限制非典型NRF2激活因子,如p21和无嘌呤/无嘧啶内切酶e1,而在NCI-H23细胞中则相反。此外,nrf2抑制因子,即叉头盒O3、p53、糖原合成酶激酶3β和类视黄醇X受体(RXR)在NCI-H23中下调,在A549细胞中上调。ICC显示,BT在A549和NCI-H23细胞中调节NRF2调节因子的共定位,如β-转导蛋白重复序列蛋白和RXR。结论:因此,BT可能改善了A549细胞的Dox潴留,提高了Dox的反应性。bt介导的选择性抑制NRF2,重新稳定不依赖keap -1的NRF2调节因子,使无应答的A549细胞对Dox部分敏感。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ayurveda and Integrative Medicine
Journal of Ayurveda and Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
4.70
自引率
12.50%
发文量
136
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书